Never Said Patanjali Medicine COULD CURE COVID-19: CEO Balkrishna


Never Said Patanjali Medicine Can Cure COVID-19: CEO Acharya Balkrishna

The Ministry of Ayush had asked Patanjali to supply information on the medicine (File)

New Delhi:

Yoga teacher Ramdev’s Patanjali Ayurved never claimed it could cure COVID-19 using its medicines, Swasari and coronil, the firm’s CEO Acharya Balkrishna said on Tuesday, adding it shared the favourable upshot of clinical trials on patients just. The Centre had barred the firm from advertising the merchandise after Ramdev, week in a sensational claim last, said they cured 280 patients within days in trials.

“We never said the medicine (coronil) could cure or control corona, we said that people had made medicines and used them in clinical controlled trial which cured corona patients. There is absolutely no confusion inside it,” Acharya Balkrishna, CEO Patanjali, was quoted as saying by news agency ANI.

The Ministry of Ayush had asked Patanjali to supply details just like the composition of the medicines, the outcomes of its research, the hospitals where in fact the research was conducted, if the company had a clearance from the Institutional Ethics Committee and whether it had registered for the clinical trials.

A licensing officer had later said the business sought a license for an “immunity booster and a cough and fever cure” also it never revealed that the merchandise were section of medicine kits. The constant state government had sent a notice to the business.

“In answer our notice, Patanjali said no Corona Kit has been packaged by them. Patanjali has printed a representative picture of coronavirus on Coronil packaging. Examples of Coronil and two other drugs have already been taken for testing,” YS Rawat, Licence Officer, Uttarakhand Ayurved Department, on Tuesday was quoted as saying by news agency ANI.

Ramdev had said the firm had collaborated with the privately-owned National Institute of Medical Sciences or NIMS University, Jaipur for clinical trials.

“We have been launching COVID medicines Coronil and Swasari today. We conducted two trials of the, first clinical controlled study, which occurred in Delhi, Ahmedabad, among a great many other cities. Under this, 280 patients were included and 100 % of these recovered. We could actually control Corona and its own complications in this. Following this the all-important clinical control trial was conducted,” he previously said.

“By using NIMS, Jaipur we conducted the clinical control study on 95 patients. The largest thing which arrived of the is that within three days 69 % patients recovered and became negative from positive (cases) and within a week 100 % of these became negative,” he added.

The highly communicable disease, which includes killed lakhs around the world, does not have any evidence-based cure currently. Doctors, however, are employing several experimental drugs and procedures that have worked for a few patients.

With inputs from ANI

Recommended For You


About the Author: zaheerdanish

He is From USA working as Journalist from Many Years for Leading Websites and News papers he is writing articles for morah dubai from past 6 months.

Leave a Reply

Your email address will not be published. Required fields are marked *